CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 282 shares at $319.99 ($90,237)
- 144 Insider Sale of Securities
- 4 Planned sale CLO & Secretary sold 5,000 shares at an average $313.22 ($1,566,094)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 2,111 shares at an average $320.30 ($676,158)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Planned sale CLO & Secretary sold 5,000 shares at an average $304.07 ($1,520,346)
- 4 Shares withheld for taxes Director gave up 115 shares (to pay taxes)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Director sold 1,200 shares at $285.00 ($342,000)
- 144 Insider Sale of Securities
- 4 Planned sale CLO & Secretary sold 5,000 shares at an average $286.09 ($1,430,434)
Page 1 of 115 · 2,297 filings